Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $1.81 Million - $2.36 Million
45,600 New
45,600 $2.36 Million
Q1 2023

Jun 13, 2024

BUY
$65.71 - $74.53 $2.63 Million - $2.98 Million
40,000 New
40,000 $2.77 Million
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $5,200 - $3.07 Million
40,000 Added 27.59%
185,000 $13.3 Million
Q1 2022

May 12, 2022

BUY
$61.48 - $73.72 $8.91 Million - $10.7 Million
145,000 New
145,000 $10.7 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.